Cleo Diagnostics (ASX:COV) Price-to-Free-Cash-Flow : (As of May. 23, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Price-to-Free-Cash-Flow?

As of today (2024-05-23), Cleo Diagnostics's share price is A$0.17. Cleo Diagnostics does not have enough years/quarters to calculate the Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023. Therefore GuruFocus does not calculate Price-to-Free-Cash-Flow Ratio at this moment.

The historical rank and industry rank for Cleo Diagnostics's Price-to-Free-Cash-Flow or its related term are showing as below:

ASX:COV's Price-to-Free-Cash-Flow is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 34.18
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Cleo Diagnostics's Free Cash Flow per Share for the six months ended in Dec. 2023 was A$-0.01.

Cleo Diagnostics Price-to-Free-Cash-Flow Historical Data

The historical data trend for Cleo Diagnostics's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Price-to-Free-Cash-Flow Chart

Cleo Diagnostics Annual Data

Trend

Jun23

Price-to-Free-Cash-Flow

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23
Price-to-Free-Cash-Flow	-	-	-

Competitive Comparison of Cleo Diagnostics's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, Cleo Diagnostics's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cleo Diagnostics's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cleo Diagnostics's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cleo Diagnostics's Price-to-Free-Cash-Flow falls into.

Cleo Diagnostics Price-to-Free-Cash-Flow Calculation

Cleo Diagnostics's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio	=	Share Price	/	Free Cash Flow per Share (TTM)
	=	0.17	/
	=

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio

Market Cap

Free Cash Flow

Cleo Diagnostics (ASX:COV) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

Cleo Diagnostics Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleo Diagnostics (ASX:COV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Price-to-Free-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines